ArticleGenes & development2026
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer.
Chunlei Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it